Page last updated: 2024-08-17

edetic acid and penicillanic acid

edetic acid has been researched along with penicillanic acid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dale, JW1
Crosby, MA; Gump, DW1
Dortet, L; Nordmann, P; Poirel, L1

Other Studies

4 other study(ies) available for edetic acid and penicillanic acid

ArticleYear
An inducible beta-lactamase in a strain of Escherichia coli.
    Antonie van Leeuwenhoek, 1975, Volume: 41, Issue:1

    Topics: Chloramphenicol; Chloromercuribenzoates; Cloxacillin; Dose-Response Relationship, Drug; Edetic Acid; Enzyme Induction; Escherichia coli; Hydrogen-Ion Concentration; Iodine; Kinetics; Mercaptoethanol; Methicillin; Molecular Weight; Oxacillin; Penicillanic Acid; Penicillin G; Penicillinase

1975
Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.
    Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:3

    Topics: Anti-Bacterial Agents; Bacteroides; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cell Membrane Permeability; Cephalosporins; Clavulanic Acids; Drug Synergism; Edetic Acid; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam

1982
[Effect of excipients on the preparation and properties of antibiotic solution for intravenous application].
    Klinicka mikrobiologie a infekcni lekarstvi, 2011, Volume: 17, Issue:4

    Topics: Anti-Bacterial Agents; Citric Acid; Edetic Acid; Excipients; Infusions, Intravenous; Injections, Intravenous; Particle Size; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Solubility

2011
Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12

    Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cost-Benefit Analysis; Drug Resistance, Multiple, Bacterial; Edetic Acid; Enterobacteriaceae; Hydrolysis; Imipenem; Penicillanic Acid; Pseudomonas; Reproducibility of Results; Tazobactam; Zinc Sulfate

2012